Form 8-K - Current report:
SEC Accession No. 0000031791-25-000006
Filing Date
2025-01-31
Accepted
2025-01-31 07:26:32
Documents
15
Period of Report
2025-01-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pki-20250131.htm   iXBRL 8-K 38175
2 EX-99.1 q42024pressrelease.htm EX-99.1 357413
  Complete submission text file 0000031791-25-000006.txt   586253

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pki-20250131.xsd EX-101.SCH 2632
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pki-20250131_def.xml EX-101.DEF 15019
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pki-20250131_lab.xml EX-101.LAB 27378
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pki-20250131_pre.xml EX-101.PRE 16135
17 EXTRACTED XBRL INSTANCE DOCUMENT pki-20250131_htm.xml XML 4022
Mailing Address 77 4TH AVENUE WALTHAM MA 02451
Business Address 77 4TH AVENUE WALTHAM MA 02451 781-663-6900
REVVITY, INC. (Filer) CIK: 0000031791 (see all company filings)

EIN.: 042052042 | State of Incorp.: MA | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-05075 | Film No.: 25575923
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)